PubMed:12875974 JSONTXT 8 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 160-417 DRI_Approach denotes To analyze differential gene expression of putative prostate tumor markers we compared the expression levels of more than 400 cancer-related genes using the cDNA array technique in a set of capsule-invasive prostate tumor and matched normal prostate tissue.
T2 418-579 DRI_Background denotes The overexpression of Bax inhibitor-1 (BI-1) in prostate carcinoma and prostate cancer cell lines was confirmed by using Northern blot and Western blot analyses.
T3 580-689 DRI_Background denotes Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) on intact RNAs from 17 paired
T4 720-813 DRI_Background denotes epithelial tissue samples confirmed up-regulated BI-1 expression in 11 of 17 prostate tumors.
T5 814-966 DRI_Outcome denotes In addition, it was demonstrated that BI-1 expression is down-regulated in stromal cells as compared to matched normal epithelial cells of the prostate.
T6 967-1098 DRI_Background denotes In situ hybridization experiments on prostate sections also revealed that BI-1 expression is mainly restricted to epithelial cells.
T7 1099-1301 DRI_Background denotes Furthermore, quantitative RT-PCR on RNAs derived from five benign prostate hyperplasia (BPH) samples showed no significant difference in BI-1 expression as compared to normal epithelial prostate tissue.
T8 1302-1563 DRI_Background denotes To determine the function of BI-1 in vitro, human PC-3, LNCaP, and DU-145 prostate carcinoma cells were transfected with small interfering double-strand RNA (siRNA) oligonucleotides against the BI-1 gene leading to a specific down-regulation of BI-1 expression.
T9 1564-1731 DRI_Background denotes Furthermore, transfection of PC-3, LNCaP, and DU-145 cells with BI-1 sequence-specific siRNAs caused a significant increase in spontaneous apoptosis in all cell lines.
T10 1732-1949 DRI_Outcome denotes Taken together, our results indicate that the human BI-1 gene contains the potential to serve as a prostate cancer expression marker and as a potential target for developing therapeutic strategies for prostate cancer.